Merritt Molly, United States, Brody discussed on C-SPAN Programming

Automatic TRANSCRIPT

S National security within the Cove. It con. Text. In October, the panel issued a call to action defining the problems, the vaccine, confidence and misinformation about vaccines as a national security threat. The call to action outlined five key recommendations. Let me briefly tell you about each one. So the rap The first one is the rapid launch of an independent panel on vaccines and misinformation to assess the decline in popular trust in science and recommend concrete measures to be taken. National states and local levels. The second relates to innovative approaches to reaching diverse and underserved populations with vaccines and other social services support by integrating the delivery of covert 19 vaccines into a broader platform of assistance, such as other kinds of health care, counseling and referrals for housing or unemployment benefits. The third recommendations centered around pledges and actions by mainstream and digital media to proactively stop this. Bread of mist and disinformation and also to promote collaboration with health providers to amplify scientific content On those platforms. The fourth centered around activism by key social and economic sectors to initiate national dialogue about vaccines and empower people to make informed choices. And the fifth recommendation in the call to action centers around federal reform, including interagency leadership of the National Security Council and increased U. S support for global immunization partners to address the issues of immunization within the larger context of confidence around health and vaccine. Now that the call to action is out, we have initiated a serious of public events to discuss the recommendations and here input from other groups. This is the first of those meetings. Our conversation today will really focus on the first recommendation in the call to action that is the establishment of an independent review panel to assess the root causes of hesitancy around covet 19 vaccines in the United States and to develop recommendations to address it. And the diverse communities where it is manifested in January and February, will host additional public meetings on each of the remaining four recommendations. That's a final report. Public launch in April to set the stage for the conversation will hear first from Dr Molly on Brody, executive vice president, chief operating officer and executive director of Public Opinion and survey research at the Kaiser Family Foundation and a co author of the recent polling analysis and the foundation's new covert 19 vaccine, monitor the monitors latest public information. Public opinion information was released yesterday. So it's really hot off the press and couldn't be timelier when vaccines are being analyzed, authorized for emergency use and distributed in many countries around the world, including now this week in the United States. And so at a moment when some media analysis groups are seeing tens of thousands of pieces of misinformation about vaccines circulating every week, the percentage of people willing to get a vaccine has risen that there are considerable variations among the demographic groups as the monitor shows. So after Marley and Brody's presentation, all hand things over to Steve Martin to introduce our next speakers and moderated discussion. So Molly and Brody let me invite you first chair, your slides and latest information now. Katherine Bliss, C s I s Global Health Policy center director at this virtual discussion Wednesday. He's so much Katherine and thank you, Steve and Heidi and everyone CFCs food, bringing all these key people together to be having these discussions and to launch just the important national conversation that we need to be having at this time, I'm going to share my screen. This is a re air. She's been radio programming from Friday. And hopefully well now see this and asked Catherine Chad, We have been tracking public reactions to and experiences with the pandemic, and certainly the subsequent development and now the distribution of the vaccine. On these results are hot off the presses on bear is, um, good news. And there's also some cause for some pause and for planning for the future, So first from the good news When it comes to the vaccine development and distribution process as of now, about two thirds of the public or at least somewhat confident that the vaccine has been properly tested for safety and effectiveness, and that will be distributed in way that is fair. Now these air shares that have increased since the recent announcements of the successful vaccine, clinical trials and since the combination of the presidential election, so with that as the good news, we also should have a note of caution that it still means about a third in each case say they're not so confident about these things in terms of the public's willingness to get vaccinated at the moment. Are certainly lots of organizations who have been asking about people's intent to get back vaccinated. And clearly you can see here that the specific questions, murder wording and the specific answer categories matter in terms of determine exact share of the public who we diem, a sort of hesitant Ranging from 27% in our recent project to 39% in the Pew Research Center's recent project, But on average, we're all getting about a third of the population is unwilling at the moment. Importantly, though, in virtually all of these cases, we've seen a decline in the shares who are hesitant and therefore an increase in the shares who are more willing to get vaccinated again. This is most likely the result that we're no longer talking about hypothetical vaccine. We're now talking about actual vaccines that people have heard about that have actually been tested. So, for example, in our own surveys, the sheriff who say they probably or definitely would not get a vaccine has fallen from 34% to 27%. Now, no matter what the actual exact estimate of the size of the hesitant group, All of the surveys are showing the same picture in terms of which of the subgroups within the public are more or less likely to be hesitant. So note here that those who self identify as Republicans, Black Americans and those living in rural areas are among those with the highest shares being reporting being at least somewhat vaccine hesitant older adults, those with serious health conditions himself. Unified Democrats are among the groups with the smallest share is likely to be hesitant when we go up the steps further and ask those who are hesitant why they feel this way. At the very top, or some reasons that are perhaps easier to address with more information an outrage like they're worried about possible side effects, or that the vaccine is new, and they just want to wait and see how it's working for other people now. Other reasons that Rice, the top suggest more complicated set of beliefs may be a play, for example, not trusting the government to make sure the vaccine is safe and effective or addressing concerns that politics has played too much of a role in the vaccine development. Process. And as you might imagine, not everyone worries about the same things. For example, note here that a much larger share of black adults for a hesitant say they're worried about the side effects and that they actually might get Cove in 19 from the vaccine. Where is much larger share of Republicans who heads a tent? They say that they feel that way because the risk of covert 19 have been exaggerated. Now. One thing that we've been very worried about is the focus on on Lee, the hesitant group that leaves out virtually all of those who are kind of in the middle group who aren't absolutely certain they would get a vaccine. We also believe that because it's such a dynamic situation, we imagine that folks are gonna be moving in between these groups. As we hear more, we've developed a way that we think allows us to look at all adults and look at how everyone sits on the question of vaccination. Not just those are hesitant. We find four groups that we think better described where the American public is at any given moment. So first is one relatively large group of 34%. That is awful being vaccine and they wanted a soon as they can get it. The challenge for this group is gonna be aligning their expectations with the actual distribution process next, the largest group about four in 10. They're generally interested in getting the vaccine. But most most of these people say they'll probably get it, although some in here say they probably won't get it. But this is the group that is likely to be the most heavily influenced by how the rollout goes and what they learned what they hear about the vaccine, safety and side effects from their trusted sources and leaders. Next. There's a small group 9% these lean against vaccination, but they do say they'll get it if they're required to now, one challenge here is that is made up disproportionately of those who are essential workers. Those people who work outside their home and maybe at highest risk for exposure Now. Merritt Molly, Excuse me, Molly and Brody Kaiser Family Foundation. There's the very resistant group just 15% of adults, but a very tough to convince a 15%. They don't plan on getting vaccinated..

Coming up next